July 17 (Reuters) - Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug ...
3h
Fatty liver often stays silent until it's too late. Here's why doctors say you shouldn't ignore it
Fatty liver often has no symptoms until significant damage occurs. Doctors explain who is at risk, early warning signs, how ...
Researchers at the University of California San Diego School of Medicine have reported results from a large international ...
The approval offers a new treatment option for adults with MASH, alongside a calorie-controlled diet and increased physical ...
The Central Drugs Standard Control Organization (CDSCO) has approved Danish major Novo Nordisk’s weight loss drug Wegovy (semaglutide injection 2.4 mg) for a new indication — fatty liver disease.
India's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of ...
It has become one of the fastest-growing causes of liver failure and liver transplantation. Many people are living with the ...
What happens to your liver when you take vitamin D supplements every day? Learn how vitamin D is processed by the liver, ...
From caviar to shark fin soup, there are numerous delicacies eaten around the world that are prized for being both rare and ...
It was actually about finding someone, so I think just being myself kind of stuck to me there and it felt like that was the ...
The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
Semaglutide was found to directly reduce liver fat, inflammation, and scarring. The approved dose for this treatment is 2.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results